Immunogenetic Predictors of Severe COVID-19

According to an analysis of published data, only 20% of patients with the new coronavirus infection develop severe life-threatening complications. Currently, there are no known biomarkers, the determination of which before the onset of the disease would allow assessing the likelihood of its severe c...

Full description

Bibliographic Details
Main Authors: Anna Malkova, Dmitriy Kudlay, Igor Kudryavtsev, Anna Starshinova, Piotr Yablonskiy, Yehuda Shoenfeld
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Vaccines
Subjects:
HLA
Online Access:https://www.mdpi.com/2076-393X/9/3/211